Hemorai is a leading brand that utilizes biophysics and Artificial Intelligence to detect hematocrit levels after delivery. Our innovative device provides a reliable and affordable alternative for acute hemorrhage detection, allowing clinicians to extend acute care to the patient's home through continuous monitoring of clinical parameters. Traditionally, patient recovery has often required costly overnight stays in hospitals for monitoring, particularly for hemorrhage risks.

This places a strain on hospital beds and resources, reducing the availability of expensive services. However, with Hemorai's cutting-edge technology, we are revolutionizing patient care. Our solution, known as Speckle Photoplethysmography (SPG), builds on the Coherent Spatial Imaging (CSI) system developed by UCI.

By combining optical property measurements with SPG-based blood flow measurements, our device enables high-speed measurements of speckle contrast and diffuse reflectance. Hemorai's team comprises industry professionals with the highest level of expertise in their respective fields. Together, we have developed a wearable device for continuous monitoring of hemorrhage, which provides critical information on pulsatile blood flow, blood volume, stO2, and tMRO2.

Hemorai stands out as the best solution for caregivers and patients, as it combines all the necessary qualities and features. If you're interested in learning more or scheduling an appointment, don't hesitate to contact us. Hemorai is dedicated to improving healthcare and expanding access to care